Mital Patel, the Executive Vice President and Chief Administrative Officer of RadNet Inc (RDNT, Financial), executed a sale of 40,000 shares of the company on June 18, 2024. The transaction was filed on the same day with the SEC. Following this transaction, the insider now owns 202,146 shares of RadNet Inc.
RadNet Inc operates as a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. The company's services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, X-ray, and mammography.
On the date of the sale, shares of RadNet Inc were priced at $59.26, valuing the company with a market cap of approximately $4.23 billion. This pricing places the company's price-earnings ratio at 190.93, significantly above the industry median of 30.17 and the company's historical median.
The GF Value of RadNet Inc is estimated at $27.92, suggesting that the stock is Significantly Overvalued with a price-to-GF-Value ratio of 2.12.
Over the past year, there have been no insider buys and 14 insider sells at RadNet Inc. Mital Patel's recent transaction of 40,000 shares aligns with this trend of insider selling, as he has not purchased any shares over the same period.
For more detailed information on RadNet Inc's financial metrics such as price-sales ratio, price-book ratio, and price-to-free cash flow, investors are encouraged to visit the respective links.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
